ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,760Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 384

$493K Total Retail Price of All Prescriptions

Rank: 61 out of 384

595 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 16,483 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$26 was the average price of a prescription from this provider, compared to $45 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 1,198 1,053 1 1
LEVOTHYROXINE SODIUM 1,001 954 2 11
METFORMIN HCL 829 710 3 2
ENALAPRIL MALEATE 790 695 4 6
GLIMEPIRIDE 588 533 5 18
OMEPRAZOLE 519 468 6 8
AMLODIPINE BESYLATE 484 449 7 3
SERTRALINE HCL 475 429 8 26
ATENOLOL 452 400 9 12
GABAPENTIN 450 386 10 4
ASPIRIN EC 429 417 11 31
FAMOTIDINE 423 360 12 35
FENOFIBRATE 421 334 13 53
LOSARTAN-HYDROCHLOROTHIAZIDE 401 324 14 10
HUMULIN N 358 300 15 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 346 339 16 78
LOSARTAN POTASSIUM 318 277 17 5
LISINOPRIL 315 256 18 14
ENALAPRIL-HYDROCHLOROTHIAZIDE 313 309 10 19 134
ALENDRONATE SODIUM 230 220 20 20
ISOSORBIDE MONONITRATE ER 229 209 21 28
PRAVASTATIN SODIUM 228 214 22 24
TAMSULOSIN HCL 206 191 23 25
RANITIDINE HCL 203 137 24 7
DOXAZOSIN MESYLATE 200 173 25 29
NABUMETONE 180 152 26 34
LEVOXYL 173 146 27 44
LOVASTATIN 167 143 28 80
METOPROLOL SUCCINATE 164 150 29 21
DIGOXIN 161 146 30 49
ATORVASTATIN CALCIUM 161 131 30 22
METOPROLOL TARTRATE 154 129 32 15
HYDROCHLOROTHIAZIDE 144 131 33 16
EVISTA 142 129 34 52
FINASTERIDE 127 115 35 62
WARFARIN SODIUM 120 96 36 48
PANTOPRAZOLE SODIUM 119 89 37 39
MECLIZINE HCL 113 107 38 73
FUROSEMIDE 108 98 39 17
CARVEDILOL 106 78 40 23
INSULIN SYRINGE 98 79 41 46
VERAPAMIL ER 98 88 41 41
BUMETANIDE 97 94 43 195
METOCLOPRAMIDE HCL 96 87 44 133
AMITRIPTYLINE HCL 92 64 R 45 75
MELOXICAM 91 84 46 85
AMLODIPINE BESYLATE-BENAZEPRIL 91 88 46 43
ATENOLOL-CHLORTHALIDONE 91 91 46 173
PREDNISONE 91 81 46 56
SYNTHROID 89 81 50 9
ZOLPIDEM TARTRATE 86 79 51 19
HUMULIN R 85 69 52 334
CITALOPRAM HBR 82 71 53 68
CALTRATE 600 + D 79 79 54 196
CLOPIDOGREL 75 60 55 30
BACLOFEN 71 61 56 109
CHLORTHALIDONE 69 44 57 316
CRESTOR 68 64 58 45
NAMENDA 67 67 59 67
TERAZOSIN HCL 66 56 60 171
PLAVIX 64 50 61 32
PENTOXIFYLLINE 62 55 62 113
GLIPIZIDE 62 56 62 27
LATANOPROST 60 60 64 76
LANSOPRAZOLE 56 40 65 86
FLUOXETINE HCL 56 49 65 36
POLYETHYLENE GLYCOL 3350 54 54 67 139
JANUMET 52 42 68 116
PAROXETINE HCL 52 42 68 37
ADVAIR DISKUS 52 49 68 65
CILOSTAZOL 51 35 71 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.